Drug industry to fight New Zealand's move to ban direct to consumer advertisingBMJ 2004; 328 doi: https://doi.org/10.1136/bmj.328.7447.1036-d (Published 29 April 2004) Cite this as: BMJ 2004;328:1036
- Bob Burton
Moves by New Zealand's health minister, Annette King, to end advertising directly to consumers later this year by “harmonising” with Australian government standards has drawn opposition from the drug industry.
In December 2003 New Zealand and Australia signed a treaty to establish a single bi-national agency to regulate medicines, medical devices, and complementary health products on 1 July 2005 (2004;328:68). The text of the treaty was tabled in both parliaments in late March and is subject to review by parliamentary committees. Supporting documentation identified direct to consumer advertising as one of the differences where efficiencies could be made. …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial